Journal Article (Letter) DKFZ-2023-01775

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results - Authors' reply.

 ;  ;

2023
Elsevier London [u.a.]

The lancet <London> / Haematology 10(9), e707 () [10.1016/S2352-3026(23)00242-9]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Note: Correspondence

Contributing Institute(s):
  1. C060 Biostatistik (C060)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2023
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Essential Science Indicators ; IF >= 20 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2023-09-01, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)